Evidence map›Paper›PMID 23118920›Full record

ArticlePloS one2012

Forkhead box protein A2 (FOXA2) protein stability and activity are regulated by sumoylation.

Narasimhaswamy S Belaguli, Mao Zhang, F Charles Brunicardi, David H Berger

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. The impact of dysregulation SUMOylation on prostate cancer.Journal of translational medicine · 2025
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. SUMOylation and phosphorylation cross-talk in hepatocellular carcinoma.Translational gastroenterology and hepatology · 2018
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Narasimhaswamy S BelaguliMichael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, USA. elaguli@bcm.edu
Mao Zhang
F Charles Brunicardi
David H Berger
Michael E. DeBakey VA Medical Center · USThe University of Texas MD Anderson Cancer Center · USUniversity of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The forkhead box protein A2 (FOXA2) is an important regulator of glucose and lipid metabolism and organismal energy balance. Little is known about how FOXA2 protein expression and activity are regulated by post-translational modifications. We have identified that FOXA2 is post-translationally modified by covalent attachment of a small ubiquitin related modifier-1 (SUMO-1) and mapped the sumoylation site to the amino acid lysine 6 (K6). Preventing sumoylation by mutating the SUMO acceptor K6 to arginine resulted in downregulation of FOXA2 protein but not RNA expression in INS-1E insulinoma cells. K6R mutation also downregulated FOXA2 protein levels in HepG2 hepatocellular carcinoma cells, HCT116 colon cancer cells and LNCaP and DU145 prostate cancer cells. Further, interfering with FOXA2 sumoylation through siRNA mediated knockdown of UBC9, an essential SUMO E2 conjugase, resulted in downregulation of FOXA2 protein levels. Stability of sumoylation deficient FOXA2K6R mutant protein was restored when SUMO-1 was fused in-frame. FOXA2 sumoylation and FOXA2 protein levels were increased by PIAS1 SUMO ligase but not a SUMO ligase activity deficient PIAS1 mutant. Although expressed at lower levels, sumoylation deficient FOXA2K6R mutant protein was detectable in the nucleus indicating that FOXA2 nuclear localization is independent of sumoylation. Sumoylation increased the transcriptional activity of FOXA2 on Pdx-1 area I enhancer. Together, our results show that sumoylation regulates FOXA2 protein expression and activity.

Indexed as

SumoylationAmino Acid MotifsAmino Acid SubstitutionAnimalsCell LineCell NucleusEnhancer Elements, GeneticGene Knockdown TechniquesHepatocyte Nuclear Factor 3-betaHomeodomain ProteinsLeupeptinsMutagenesis, Site-DirectedProteasome Endopeptidase ComplexProteasome InhibitorsProtein Inhibitors of Activated STATProtein Stabilitybenzyloxycarbonylleucyl-leucyl-leucine aldehydeFoxa2 protein, ratHepatocyte Nuclear Factor 3-betaHomeodomain ProteinsLeupeptinspancreatic and duodenal homeobox 1 proteinProteasome Endopeptidase ComplexProteasome InhibitorsProtein Inhibitors of Activated STATRNA, Small InterferingTrans-ActivatorsUbiquitin-Conjugating EnzymesUbiquitin-Conjugating Enzyme UBC9

Identifiers

PMID23118920
PMCPMC3485284
OpenAlexW1994925512

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.